| 12410183 |
Sars-cov2 main protease inhibitors |
Stephen E. Ammann, Xinpei Cai, Weng K. Chang, Gregory Chin, Henok H. Kinfe +9 more |
2025-09-09 |
|
| 12398160 |
Cot modulators and methods of use thereof |
Manoj C. Desai, Eric Gorman, Jiayao Li, Roland D. Saito, James G. Taylor +1 more |
2025-08-26 |
|
| 12240862 |
Inhibitors of peptidylarginine deiminases |
Daniel H. Byun, Laurent P. Debien, Petr Jansa, Rick Lee, Jennifer A. Loyer-Drew +10 more |
2025-03-04 |
|
| 12091420 |
SARS-COV2 main protease inhibitors |
Stephen E. Ammann, Xinpei Cai, Weng K. Chang, Gregory Chin, Henok H. Kinfe +8 more |
2024-09-17 |
$320,643,000 |
| 12070455 |
Thienopyrrole compounds |
Stephen E. Ammann, Weng K. Chang, Henok H. Kinfe, Scott E. Lazerwith, Michael L. Mitchell +3 more |
2024-08-27 |
$638,061,000 |
| 11976083 |
Inhibitors of peptidylarginine deiminases |
Weng K. Chang, Laurent P. Debien, Petr Jansa, Jennifer A. Loyer-Drew, Luisruben P. MARTINEZ +10 more |
2024-05-07 |
$81,908,000 |
| 11878965 |
Inhibitors of peptidylarginine deiminases |
Daniel H. Byun, Zhenhong R. Cai, Laurent P. Debien, Timothy R. Hansen, Richard Huang +13 more |
2024-01-23 |
$552,258,000 |
| 11827662 |
Cot modulators and methods of use thereof |
Manoj C. Desai, Eric Gorman, Jiayao Li, Roland D. Saito, James G. Taylor +1 more |
2023-11-28 |
$233,454,000 |
| 11753399 |
Therapeutic compounds |
Gediminas Brizgys, Chienhung Chou, Michael Graupe, Jiayao Li, Roland D. Saito +4 more |
2023-09-12 |
$558,049,000 |
| 11661431 |
Thienopyrrole compounds |
Stephen E. Ammann, Weng K. Chang, Henok H. Kinfe, Scott E. Lazerwith, Michael L. Mitchell +4 more |
2023-05-30 |
$275,933,000 |
| 11325930 |
Cot modulators and methods of use thereof |
Manoj C. Desai, Eric Gorman, Jiayao Li, Roland D. Saito, James G. Taylor +1 more |
2022-05-10 |
$207,189,000 |
| 11267801 |
Therapeutic compounds |
Gediminas Brizgys, Chienhung Chou, Michael Graupe, Jiayao Li, Roland D. Saito +4 more |
2022-03-08 |
$63,247,000 |
| 10947259 |
Cot modulators and methods of use thereof |
Manoj C. Desai, Eric Gorman, Jiayao Li, Roland D. Saito, James G. Taylor +1 more |
2021-03-16 |
$350,729,000 |
| 10836746 |
Therapeutic compounds |
Gediminas Brizgys, Chienhung Chou, Michael Graupe, Jiayao Li, Roland D. Saito +4 more |
2020-11-17 |
$177,245,000 |
| 10603318 |
Inhibitors of hepatitis C virus |
Jeromy J. Cottell, Kapil Kumar Karki, Ashley Anne Katana, Darryl Kato, Tetsuya Kobayashi +15 more |
2020-03-31 |
|
| 10442804 |
Compounds for the treatment of hepatitis B virus infection |
Evangelos Aktoudianakis, Kevin S. Currie, Darryl Kato, Jiayao Li, John O. Link +7 more |
2019-10-15 |
$386,222,000 |
| 10335409 |
Inhibitors of hepatitis C virus |
Kyla Bjornson, Jeromy J. Cottell, Kapil Kumar Karki, Ashley Anne Katana, Darryl Kato +15 more |
2019-07-02 |
|
| 9981955 |
Antiviral compounds |
Elizabeth M. Bacon, Aesop Cho, Jeromy J. Cottell, Manoj C. Desai, Michael Graupe +23 more |
2018-05-29 |
|
| 9951043 |
Therapeutic compounds |
Gediminas Brizgys, Chien-Hung Chou, Michael Graupe, Randall L. Halcomb, Yunfeng Eric Hu +9 more |
2018-04-24 |
$155,957,000 |
| 9873680 |
Therapeutic compounds |
Gediminas Brizgys, Randall L. Halcomb, Yunfeng Eric Hu, Darryl Kato, John O. Link +4 more |
2018-01-23 |
$174,109,000 |
| 9655944 |
Inhibitors of hepatitis C virus |
Kyla Bjornson, Jeromy J. Cottell, Kapil Kumar Karki, Ashley Anne Katana, Darryl Kato +15 more |
2017-05-23 |
$417,828,000 |
| 9511056 |
Antiviral compounds |
Elizabeth M. Bacon, Aesop Cho, Jeromy J. Cottell, Manoj C. Desai, Michael Graupe +23 more |
2016-12-06 |
|
| 9321753 |
Inhibitors of Flaviviridae viruses |
Michael O'Neil Hanrahan Clarke, Scott E. Lazerwith, Willard Lew, Philip Anthony Morganelli, William J. Watkins |
2016-04-26 |
$323,548,000 |
| 9296782 |
Inhibitors of hepatitis C virus |
Kyla Bjornson, Jeromy J. Cottell, Kapil Kumar Karki, Ashley Anne Katana, Darryl Kato +15 more |
2016-03-29 |
$161,020,000 |
| 8884030 |
Inhibitors of Flaviviridae viruses |
Lee S. Chong, Michael O'Neil Hanrahan Clarke, Edward Doerffler, Scott E. Lazerwith, Willard Lew +3 more |
2014-11-11 |
$461,366,000 |